Pfizer's Antiviral Pill Shows Potentially Game-Changing Results

Last Thursday, the drugmaker went public with preliminary results for its experimental antiviral pill for COVID-19.

We're looking at two simultaneous narratives when it comes to the pandemic. The Delta variant is driving up COVID-19 hospitalizations in the mountain west, which is a worrying sign as we head into winter. On the other hand, breakthrough treatments could soon be game changers.

Last Thursday, drug maker Pfizer went public with preliminary results for its experimental antiviral pill for COVID-19.

"Within three days of the symptoms, you have now 89% protection from disease leading to hospitalization with our medicines, and the data indicate 100% protection from death," Pfizer's Dr. Mikael Dolsten said.